# Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

> **NCT07471230** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Biocells Medical** · enrollment: 120 (estimated)

## Conditions studied

- Parkinsonism or Parkinson's Disease Nos
- Parkinsonism in Diseases Classified Elsewhere

## Interventions

- **BIOLOGICAL:** Intrathecal (IT)
- **BIOLOGICAL:** Intravenous

## Key facts

- **NCT ID:** NCT07471230
- **Lead sponsor:** Biocells Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-23
- **Primary completion:** 2028-11-23
- **Final completion:** 2029-11-23
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07471230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07471230, "Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07471230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*